|
|
||||||||
577.1 |
1 Center for Regenerative Medicine, ZMF at UKT, Tübingen, Germany
2 Gynaecology
3 Anestesiology, UKT, Tübingen, Germany
ABSTRACT
Objectives: Human term placenta is a promising source of mesenchymal stromal cells (MSC). After expansion in GMP-compatible medium containing human-platelet-rich plasma, these cells could be utilized in regenerative medicine. In our study we examined the properties of pMSC in comparison to bmMSC.
Methods: PMSC were isolated from term placenta and expanded in FCS-free, GMP-compatible medium. Characteristic MSC antigen expression of plastic adherent cells was observed by flow cytometry. Differentiation to adipogenic, osteogenic and chondrogenic lineages was detected by cytochemistry and immunostaining. Marker gene expression was measured by quantitative RT-PCR.
Results: PMSC can be expanded efficiently in GMP-compatible medium while retaining their typical antigen expression and showing differentiation potential comparable to that of BM MSC.
Conclusion: Human term placenta can be used as a ethically unobjectionable source of MSC and represent a non-invasive alternative to bmMSC. The cultivation of MSC in "GMP-compatible medium" allows rapid expansion to provide the necessary cell numbers for tissue engineering
| ||||||||||||||||||||||||||||||||||||||||||||